Mobocertinib (TAK788)
Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR) and HER2 mutations. Mobocertinib (TAK788) is an antineoplastic agent.
| Trivial name | AP32788 |
| Catalog Number | S6813 |
| CAS# | 1847461-43-1 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/tak788.html |
| Additional Information | https://file.selleck.cn/downloads/struct/tak788-chemical-structure-s6813.gif |